Skip to main content
Equibles

GSK · GSK plc · Metrics

Track GSK — free

Use GSK with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GSK.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$47.03 -0.15 (-0.32%) At close · Oct 2
Rebalance outlook locked
Market Cap
$98.62B
Shares
2.00B
Volume · Oct 2 5.39M Avg daily vol (3M) 3.68M

GSK metrics

53 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$47.03
Market cap
$98.62B

Price action

20 metrics
Price change (1W)
-4.5%
Price change (30D)
-7.5%
Price change (3M)
-12.4%
Price change (6M)
-17.0%
Price change (YTD)
-4.1%
Price change (1Y)
+7.6%
Trailing year
Price change (5Y)
—
52-week high
$61.18
52-week low
$43.24
Change from 52-week high
-23.1%
Change from 52-week low
+8.8%
Annualized volatility
26.1%
Annualized volatility (3M)
24.8%
Beta
0.3
RSI (14D)
33.8
Price vs SMA 50
-7.1%
Price vs SMA 200
-10.3%
Avg volume (3M)
3.68M
Relative volume
1.5
Average dollar volume
$187.44M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - General
Shares outstanding
2.00B

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
4.5
reciprocal yield 22.3%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-10-28
Last earnings
2026-07-28

Profitability

9 metrics
Gross margin
72.4%
Operating margin
24.3%
Trailing 12 months
Net margin
17.5%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$7.59

Growth

11 metrics
Revenue growth YoY
+4.1%
Year over year
Net income growth YoY
+122.0%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
+123.2%
Shares change YoY
+0.0%
Year over year · more shares
Revenue CAGR (3Y)
+3.7%
Revenue CAGR (5Y)
+6.0%
EPS CAGR (3Y)
-27.6%
EPS CAGR (5Y)
-0.5%
FCF CAGR (3Y)
+0.7%
FCF CAGR (5Y)
-3.0%

Quality

14 metrics
Return on equity
34.9%
Return on assets
9.4%
Debt / equity
—
Current ratio
0.8
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$4.57B
Total assets
$82.19B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
1,057
13F filer change QoQ
+9
Institutional ownership
17.5%

Short interest

3 metrics
Short interest
0.7%
Latest settlement · 5.5 days to cover
Days to cover
5.5d
Short-squeeze score
53 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1131399 CUSIP 37733W204 13F (30d) 32 filings 22 filers Visit website Investor relations